Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies

por Jedlička, Marek, Feglarová, Tereza, Janstová, Lucie, Hortová-Kohoutková, Marcela, Frič, Jan
Publicado 2022

RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS

por Kaisrlikova, Monika, Vesela, Jitka, Kundrat, David, Votavova, Hana, Dostalova Merkerova, Michaela, Krejcik, Zdenek, Divoky, Vladimir, Jedlicka, Marek, Fric, Jan, Klema, Jiri, Mikulenkova, Dana, Stastna Markova, Marketa, Lauermannova, Marie, Mertova, Jolana, Soukupova Maaloufova, Jacqueline, Jonasova, Anna, Cermak, Jaroslav, Belickova, Monika
Publicado 2022